Serum Institute CEO Adar Poonawala with PM Modi

Pune. Serum Institute of India (SII) CEO Adar Poonawalla said that the UK pharmaceutical company AstraZeneca has sent a legal notice to manufacturing partner Pune’s SII over the delay in the supply of the COVID-19 vaccine.

According to Business Standard, Poonwala told, ‘I cannot comment on the legal notice. It is confidential, but we are investigating all avenues to manage and resolve legal disputes over contractual obligations. ‘ Reports said the notice came after Serum Institute delayed the shipment of vaccines to the UK. Also, the Indian government is also aware of the legal notice.

3,000 crores needed to increase vaccine production
With this, Poonawala said on Tuesday that to increase the production capacity of Covid-19 vaccine, about Rs 3,000 crore will be needed. Poonawala said, ‘We need roughly Rs 3,000 crore, which is not a small figure, because we have already spent thousands of crores of rupees. We have to find other new ways to build our capacity. ” He said that the company expects the production capacity of the Covishield vaccine to increase to 11 crore per month from June. Poonawala said that the company is producing 20 lakh doses per day.

He said, “We have given more than 100 million doses in India alone and exported about 60 million doses to other countries.” Apart from the serum institute, other vaccine producers have also agreed with the government for not taking profits.

He said that no other vaccine company in the world is providing vaccines at such reduced prices. Poonawala said in another interview that the Serum Institute is giving priority to India’s temporary needs over others. The company is currently producing six to seven crore vaccines per month.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *